Verition Fund Management
ENTX icon

Verition Fund Management’s Entera Bio ENTX Stock Holding History

Verition Fund Management’s Portfolio ENTX Stock Details ENTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-30,523
Closed -$183K – 2008
2021
Q2 		$183K Buy
+30,523
New +$113K ﹤0.01% 1617

Other funds holding ENTX

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
SFI
Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Verition Fund Management's ENTX Position: Q3 2021 in Review

Verition Fund Management sold out of Entera Bio (ENTX) in Q3 2021, closing a stake of 30,523 shares — an estimated $183K sold.

Verition Fund Management first reported a position in ENTX in Q2 2021 and held it in 1 quarter. The position peaked at $183K in Q2 2021. 14 funds tracked by Wall St. Rank hold ENTX as of Q3 2021.

  • Verition Fund Management reported no remaining Entera Bio position as of Q3 2021 after selling out during the quarter.
  • Verition Fund Management sold 30,523 Entera Bio shares in Q3 2021, an estimated $183K.
  • Verition Fund Management first reported a position in Entera Bio in Q2 2021 and held it in 1 quarter.
  • Verition Fund Management's Entera Bio position peaked at $183K in Q2 2021.
  • 14 funds tracked by Wall St. Rank held Entera Bio as of Q3 2021.

Based on Verition Fund Management's 13F filing for Q3 2021, filed 15 Nov 2021.